180 Life Sciences Corp.
Q2 2024 13F Holders
Symbol
ETHZ
CUSIP
68236V302
Type
Equity
Class
COM
Num filings
9
Total reported value, excl. options
$11.6 k
Compare 2024 Q2 to
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type